Emilie T.E. Gross

Emilie joined BioSymetrics in April 2023 as Director of Business Development. Her scientific background is mainly focused on Oncology and Immunology, and she's been working in biotech business development roles for the last five years. Emilie completed her undergraduate studies in Nottingham, England, her Ph.D. at the Paul Sabatier University in Toulouse, France, and her post-doctoral research at the University of California San Diego. Emilie recently graduated with her Executive MBA from Quantic University.